87326-78-1

Basic information

• Product Name: methyl 3-O-benzyl-β-L-idopyranuronate
• Synonyms: methyl 3-O-benzyl-β-L-idopyranuronate
• CAS NO: 87326-78-1
• Molecular Weight: 298.293
• Mol File: 87326-78-1.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: methyl 3-O-benzyl-β-L-idopyranuronate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-O-benzyl-β-L-idopyranuronate(87326-78-1)
• EPA Substance Registry System: methyl 3-O-benzyl-β-L-idopyranuronate(87326-78-1)

Safety Data

• Hazardous Substances Data: 87326-78-1(Hazardous Substances Data)

Upstream product

• 22529-61-9 (1R)-1-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro(2,3-d)(1,3)dioxol-5-yl)ethane-1,2-diol 
• 100-39-0 benzyl bromide 
• 18685-18-2 3-O-benzyl-1,2-5,6-O-diisopropylidene-α-D-glucofuranose 
• 23558-05-6 3-O-benzyl-1,2-O-isopropylidene-1,5-D-xylo-dialdofuranose 
• 243982-76-5 5-O-Pivaloyl-L-iduronolactone 
• 87326-76-9 methyl 3-O-benzyl-1,2-O-isopropylidene-α-L-idofuranosiduronate 
• 37073-70-4 1-(6-benzyloxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-trityloxyethanol 
• 87326-75-8 (R)-((3aR,5S,6S,6aR)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-trifluoromethanesulfonyloxy-acetic acid methyl ester 
• 87326-74-7 (S)-((3aR,5S,6S,6aR)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-trifluoromethanesulfonyloxy-acetic acid methyl ester 
• 87326-73-6 (S)-methyl 2-((3aR,5R,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-hydroxyacetate 
• 92955-34-5 5-O-acetyl-3-O-benzyl-1,2-O-isopropylidene-6-O-trityl-α-D-glucofuranose 
• 87326-72-5 3-O-benzyl-1,2-O-isopropyridene-α-D-glucofuranuronic acid 
• 262382-45-6 tris(thiophenyl) 3-O-benzyl-1,2-O-isopropylidene-β-L-orthoidofuranuronate 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 

Downstream Products

• 243982-79-8 methyl (dimethylthexylsilyl 3-O-benzyl-β-L-idopyranoside)uronate 
• 87326-76-9 methyl 3-O-benzyl-1,2-O-isopropylidene-α-L-idofuranosiduronate 
• 444118-44-9 1,2-O-isopropylidene-3-O-benzyl-4-O-trichloroacetyl-6-methyl-α-L-idonic acid 
• 444118-45-0 methyl 3-O-benzyl-1,2-O-cyclopentylidene-β-L-idopyranosyluronate 
• 615542-95-5 methyl 4-O-allyl-3-O-benzyl-1,2-O-isopropylidene-α-L-idopyranosiduronate 
• 615542-98-8 methyl 3,4-di-O-benzyl-1,2-O-isopropylidene-α-L-idopyranosiduronate 
• 615543-24-3 methyl 1,2-di-O-acetyl-4-O-allyl-3-O-benzyl-β-L-idopyranosiduronate 
• 615543-00-5 methyl 3-O-benzyl-1,2-O-isopropylidene-4-O-levulinoyl-α-L-idopyranosiduronate 
• 615543-04-9 methyl 2-O-acetyl-4-O-allyl-3-O-benzyl-L-idopyranosiduronate trichloroacetimidate 
• 615543-20-9 methyl 2-O-acetyl-3-O-benzyl-4-O-levulinoyl-L-idopyranosiduronate trichloroacetimidate 
• 615543-18-5 methyl 3-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-L-idopyranosiduronate trichloroacetimidate 

Relevant articles and documents

Formal synthesis of a disaccharide repeating unit (IdoA-GlcN) of heparin and heparan sulfate

A concise route to access the key disaccharide repeating unit (IdoA-GlcN) of heparan sulfate is described. The synthesis was accomplished by commercially available diacetone α-d-glucose to functional group transformations, which led to the formation of a

SACCHARIDE STRUCTURES AND METHODS OF MAKING AND USING SUCH STRUCTURES

Described are oligosaccharides having a protecting group at two, a plurality, a majority of, or each position in the oligosaccharide which is amenable to derivatization. Collections, libraries and methods of making and using such oligosaccharides are also

Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same

Compound capable of binding to gamma-interferon (γ-IFN), chosen from the molecules corresponding to formula (I) below: in which X is a divalent spacer group that is sufficiently long to allow the two oligosaccharide fragments A and B to each bind to one of the peptide sequences 125 to 143 of the C-terminal ends of a γ-interferon (γ-IFN) homodimer, n represents an integer from 0 to 10, and for example equal to 0, 1, 2, 3, 4 or 5, and each R independently represents a hydrogen atom, an SO3? group or a phosphate group, on the condition that no SO3? group is in the 3-position of the glucosamine units of compound (I). The invention also relates to the process for preparing these compounds, to the complexes formed by these compounds and gamma-interferon, and to the medicaments comprising these compounds or complexes.